Page last updated: 2024-10-25

debrisoquin and Agranulocytosis

debrisoquin has been researched along with Agranulocytosis in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Research Excerpts

ExcerptRelevanceReference
" These same two sisters had previously developed agranulocytosis in association with carbimazole therapy."7.67The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis. ( Crothers, MJ; Idle, JR; Ritchie, JC; Shah, RR; Smith, RL, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ritchie, JC1
Crothers, MJ1
Shah, RR1
Idle, JR1
Smith, RL1

Other Studies

1 other study available for debrisoquin and Agranulocytosis

ArticleYear
The metabolism of debrisoquine in man: (1) regioselectivity of hydroxylation and (2) aberrant oxidative metabolism in two sibling patients with carbimazole-induced agranulocytosis.
    Xenobiotica; the fate of foreign compounds in biological systems, 1986, Volume: 16, Issue:5

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Carbimazole; Child; Debrisoquin; Female; Humans; Hydroxyla

1986